Transdermal Delivery Rate Control Using Amorphous Pharmaceutical Compositions

Patent No. EP1534235 (titled "Transdermal Delivery Rate Control Using Amorphous Pharmaceutical Compositions") was filed by Acrux DDS on Jun 24, 2003. The application was issued on Jul 27, 2016.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP1534235

ACRUX DDS
Application Number
EP03729716A
Filing Date
Jun 24, 2003
Status
Revoked
Feb 22, 2019
Publication Date
Jul 27, 2016